{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-000799","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2023-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.149992+00:00","generated_at":"2026-06-19T22:48:47.922410+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cosmos Health appoints Nikos Bardakis as COO; Pavlos Ignatiades moves to CCO","bullets":["Nikos Bardakis appointed COO effective Feb 1, 2023, with over 20 years international pharma experience.","Bardakis previously National Sales Director at Servier Hellas, managing 130+ employees.","Pavlos Ignatiades transitions from COO to Chief Communications Officer (CCO).","Ignatiades had been COO since 2020, responsible for Nasdaq listing and investor relations.","CEO Greg Siokas states moves support multi-layered growth strategy and transformation to healthcare company."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-000799","json":"https://secwatch.observer/filing/0001477932-23-000799.json","markdown":"https://secwatch.observer/filing/0001477932-23-000799.md","text":"https://secwatch.observer/filing/0001477932-23-000799.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223000799/0001477932-23-000799-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223000799/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T22:48:47.922410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1966453c42","claim":"Nikos Bardakis was appointed as Chief Operating Officer (COO) at Cosmos Health Inc..","evidence_excerpt":"On February 1, 2023, Cosmos Health Inc. (the 'Company') announced the appointment of Nikos Bardakis (54), who comes with over two decades of international branded pharmaceutical sector experience, as the Chief Operating Officer (COO).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223000799/0001477932-23-000799-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer (COO)"}],"fact_type":"executive_change"},{"claim_id":"a7f91a7149","claim":"Pavlos Ignatiades was appointed as Chief Communications Officer (CCO) at Cosmos Health Inc..","evidence_excerpt":"Nikos Bardakis will succeed Pavlos Ignatiades, who will assume the position of Chief Communications Officer (CCO).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223000799/0001477932-23-000799-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Communications Officer (CCO)"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}